Anil Paramesh

Dr. Anil Paramesh

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2012 in Transplantation
Verified
Journal Article
Closed access
APAnil Paramesh
Anil Paramesh
JDJohn Y. Davis
John Y. Davis
CMChaitanya Mallikarjun
Chaitanya Mallikarjun
RZRubin Zhang
Rubin Zhang
RCRobert Cannon
Robert Cannon
JBJoseph F. Buell
Joseph F. Buell
Background Kidney transplantation (KTx) alone in patients with cirrhosis and renal failure (end-stage renal disease [ESRD]) infected with hepatitis C virus (HCV) is controversial. The aim of this study was to compare outcomes of HCV+ patients with ESRD and cirrhosis (C group) versus HCV+ patients with ESRD but with no cirrhosis (NC group) listed for KTx. Methods Ninety HCV+ patients with ESRD were evaluated for KTx between 2003 and 2010. Listed patients underwent transjugular liver biopsy with hepatic portal venous gradient (HPVG) measurements. Only patients with HPVG less than 10 mm Hg were considered for KTx alone. We analyzed patient demographics, waitlist/liver disease characteristics, and posttransplant outcomes between groups. Results Sixty-four patients listed for KTx alone were studied. Twelve patients (18.75%) showed biopsy-proven cirrhosis. Thirty-seven patients underwent KTx alone (9 from C and 28 from NC). No patients developed decompensation of their liver disease, although one patient for NC group developed metastatic hepatocellular carcinoma 16 months after transplantation. One- and three-year graft survival rates were 75% and 75% versus 92.1% and 75.1% for groups C and NC, respectively (P=0.72). One- and three-year patient survival rates were 88.9% and 88.9% versus 96.3% and 77.9% for groups C and NC, respectively (P=0.76). Only increasing recipient age and decreasing albumin levels were significantly associated with worse graft and patient survival. Conclusions Our study suggests that KTx alone may be safe in patients with compensated HCV, cirrhosis, and ESRD with HPVG less than 10 mm Hg. A simultaneous liver-kidney transplantation may be an unnecessary use of a liver allograft in these patients.

9 December 2014 in Transplantation Proceedings
Verified
Journal Article
Closed access
ASA. Smith
A. Smith
RCR. Couvillion
R. Couvillion
RZR. Zhang
R. Zhang
MKM. Killackey
M. Killackey
JBJ. Buell
J. Buell
APAnil Paramesh
Anil Paramesh

1 January 2014 in JSLS : Journal of the Society of Laparoscopic & Robotic Surgeons
Verified
Journal Article
Open access
AHAdam T. Hauch
Adam T. Hauch
PLPeter W. Lundberg
Peter W. Lundberg
APAnil Paramesh
Anil Paramesh
Continuous ambulatory peritoneal dialysis has become an increasingly popular modality of renal replacement therapy. Laparoscopic placement of peritoneal dialysis catheters may help overcome previous barriers to peritoneal dialysis, such as previous abdominal ...

1 November 2010 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
APAnil Paramesh
Anil Paramesh
RZRubin Zhang
Rubin Zhang
JBJohn Baber
John Baber
CYC. L. Yau
C. L. Yau
DSDouglas P. Slakey
Douglas P. Slakey
SFSander S. Florman
Sander S. Florman

1 November 2020 in Journal of Surgical Education
Verified
Journal Article
Closed access
RSRebecca Schroll
Rebecca Schroll
APAnil Paramesh
Anil Paramesh
CGChrissy Guidry
Chrissy Guidry
MZMatthew Zelhart
Matthew Zelhart
MKMary Killackey
Mary Killackey
SLShauna Levy
Shauna Levy

9 April 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
MPMatthew Pittappilly
Matthew Pittappilly
MSMoh'd Ahmed Sharshir
Moh'd Ahmed Sharshir
APAnil Paramesh
Anil Paramesh
Chronic allograft nephropathy is the leading cause of kidney allograft failure. Clinically, it is characterized by a progressive decline in kidney function, often in combination with proteinuria and hypertension. Histologically, interstitial fibrosis and tubular atrophy, along with features of glomerulosclerosis with occasional double contour appearance, arteriolar hyalinosis, and arteriosclerosis, are characteristic findings. The pathophysiology, though complex and incompletely understood, is thought to involve a sequence of immunologic and non-immunologic injuries eventually leading to tissue remodeling and scarring within the graft. The optimal strategy to prevent chronic allograft nephropathy is to minimize both immune- and non-immune-mediated graft injury.